NESTLEIND - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.1
| Stock Code | NESTLEIND | Market Cap | 2,74,207 Cr. | Current Price | 1,422 ₹ | High / Low | 1,499 ₹ |
| Stock P/E | 79.4 | Book Value | 27.5 ₹ | Dividend Yield | 0.84 % | ROCE | 84.2 % |
| ROE | 73.2 % | Face Value | 1.00 ₹ | DMA 50 | 1,364 ₹ | DMA 200 | 1,279 ₹ |
| Chg in FII Hold | -0.07 % | Chg in DII Hold | 0.30 % | PAT Qtr | 1,141 Cr. | PAT Prev Qtr | 881 Cr. |
| RSI | 55.4 | MACD | 25.6 | Volume | 13,68,735 | Avg Vol 1Wk | 17,91,162 |
| Low price | 1,085 ₹ | High price | 1,499 ₹ | PEG Ratio | 6.06 | Debt to equity | 0.08 |
| 52w Index | 81.4 % | Qtr Profit Var | 28.8 % | EPS | 18.4 ₹ | Industry PE | 54.5 |
📊 Financials: The company demonstrates exceptional profitability with ROE at 73.2% and ROCE at 84.2%, reflecting outstanding efficiency in capital usage. Debt-to-equity is low at 0.08, showing a strong balance sheet. Quarterly PAT rose from ₹881 Cr. to ₹1,141 Cr., a 28.8% increase, highlighting strong earnings momentum. EPS of ₹18.4 supports consistent cash flow generation.
💹 Valuation: Current P/E of 79.4 is significantly higher than the industry average of 54.5, suggesting overvaluation. The PEG ratio of 6.06 indicates growth prospects are limited relative to price. Book value of ₹27.5 against a market price of ₹1,422 implies a stretched P/B ratio. Intrinsic value appears lower than current levels, requiring caution despite strong fundamentals.
🏭 Business Model: The company operates in FMCG, with a strong portfolio of food and beverage products. Competitive advantage lies in brand strength, distribution network, and consumer loyalty. Consistent demand and pricing power support long-term stability, though valuations remain stretched.
📈 Entry Zone: A favorable entry would be closer to ₹1,350–1,380, near the 50 DMA of ₹1,364. Current price of ₹1,422 is above fair value, so accumulation on dips is recommended.
⏳ Long-Term Holding: Strong fundamentals, brand dominance, and consistent profitability make it suitable for long-term holding. However, stretched valuations suggest cautious accumulation rather than aggressive buying.
Positive
- ✅ Exceptional ROE (73.2%) and ROCE (84.2%)
- ✅ Low debt-to-equity ratio (0.08)
- ✅ Strong quarterly PAT growth (₹1,141 Cr. vs. ₹881 Cr.)
- ✅ Dividend yield of 0.84% adds shareholder value
Limitation
- ⚠️ Very high P/E (79.4) compared to industry average
- ⚠️ Stretched P/B ratio (Price ₹1,422 vs. Book Value ₹27.5)
- ⚠️ PEG ratio of 6.06 indicates limited growth prospects
Company Negative News
- 📉 Decline in FII holding (-0.07%) shows reduced foreign investor confidence
Company Positive News
- 📈 Increase in DII holding (+0.30%) reflects strong domestic institutional support
- 📈 PAT growth highlights operational strength
Industry
- 🥫 FMCG sector benefits from consistent consumer demand
- 📊 Industry P/E at 54.5 suggests peers are valued lower
- 🌍 Growth opportunities in packaged foods, beverages, and emerging markets
Conclusion
Overall, the company is financially strong with exceptional return ratios, brand dominance, and consistent earnings growth. However, valuations are stretched compared to peers, limiting upside potential. Best strategy is cautious accumulation near ₹1,350–1,380 for long-term holding, while avoiding aggressive buying at current levels.
Would you like me to extend this with a peer comparison against other FMCG companies, or a technical analysis view to highlight support/resistance and momentum indicators?